Technology | February 04, 2015

Ostar Launches First Cellular TeleHealth Blood Pressure System for CHF

Product is an affordable cellular blood pressure solution for congestive heart failure

Blood pressure monitoring, hypertension, heart failure, remote monitoring, OSTAR

Images courtesy of Ostar

Blood pressure monitoring, hypertension, heart failure, remote monitoring, OSTAR

February 4, 2015 — Ostar Healthcare Technology, a Washington State Based TeleHealth Solutions company, announced the North American launch of Cellular TeleHealth Blood Pressure Monitoring System. This chronic disease remote monitoring system aids in reduction of 30-day readmission rates for heart patients, in particular Congestive Heart Failure (CHF). According to Doug Hemenway, CEO, "This North American launch of Ostar Cellular P201 brings forth another market first, a unique cell enabled health device with a combined data gateway approach, with ability to use the Ostar health insurance card reader. The Ostar P201, delivers more than real time remote blood pressure monitoring, it also provides data input gateway ability, accepting and transmitting other patient centered data from Glucometers, Weight Scales and all other vital signs devices. All Ostar products reinforce Ostar's commitment to advanced remote monitoring, reducing 30 day readmission rates, in line with (CMS) edicts, improving patient outcomes, avoiding unnecessary costs, as required by Accountable Care Act (PPACA)."

Ostar Healthcare Technology – P201 Remote TeleHealth Blood Pressure Gateway System, provides a cellular device with combined mHealth Personal Dashboard app, seamlessly transmitting relevant data to population health management systems, wellness platforms, EMR's and HIE's, anywhere in the world. Ostar Healthcare Technology – P201 Remote Cellular TeleHealth Blood Pressure Gateway System is the first Cellular P Series to be released.

Paul A. Markham, M.D., chief operating officer of Ostar Healthcare Technology commented:

"Given the current transformation of healthcare in the United States, this simple cellular enabled, insurance card enabled, remote TeleHealth solution, has the potential to positively impact advanced chronic disease management outcomes. The concept will impact shared saving plans in Accountable Care Organizations, while also positively impacting health insurance indicators such as HEDIS, with regards to Medicare Advantage Star Rating programs."

For more information:



Related Content

Heart Failure Market to Surpass $16 Billion by 2026
News | Heart Failure| September 19, 2017
The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain, the U.K. and Japan is...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Systolic Blood Pressure at Time of STEMI PCI May Predict In-Hospital Mortality
News | Cath Lab| September 11, 2017
September 11, 2017 — Researchers have led a retrospective single-center...
Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure| September 06, 2017
September 6, 2017 — Physicians identified a majority of patients with advanced...
Text Messaging Could Help Tackle High Blood Pressure in At-Risk Patients

Image courtesy of Michigan Medicine

News | Hypertension| September 06, 2017
A new National Institutes of Health-funded hypertension trial will examine the possibility of using an emergency...
Israeli Hospital Completes First Implant of CORolla Heart Failure Device
News | Heart Failure| September 05, 2017
Rambam Hospital in Haifa, Israel, recently became the first to use the CORolla device from Israeli start-up company...
SPYRAL HTN-OFF MED Study Results Show Efficacy, Safety of Renal Denervation
News | Renal Denervation| August 31, 2017
Medtronic plc announced its intent to move forward with a new renal denervation pivotal trial following positive first...
MobiusHD Device Shows Promise in Treatment of Resistant Hypertension
News | Hypertension| August 30, 2017
Vascular Dynamics Inc. announced interim results of the company’s first-in-human trial of its MobiusHD implant...
Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System
Technology | Ventricular Assist Devices (VAD)| August 29, 2017
Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left...
Sponsored Content | Videos | Cardiovascular Ultrasound| August 28, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Overlay Init